Hypergraph models of biological networks to identify genes critical to pathogenic viral response
- PMID: 34051754
- PMCID: PMC8164482
- DOI: 10.1186/s12859-021-04197-2
Hypergraph models of biological networks to identify genes critical to pathogenic viral response
Abstract
Background: Representing biological networks as graphs is a powerful approach to reveal underlying patterns, signatures, and critical components from high-throughput biomolecular data. However, graphs do not natively capture the multi-way relationships present among genes and proteins in biological systems. Hypergraphs are generalizations of graphs that naturally model multi-way relationships and have shown promise in modeling systems such as protein complexes and metabolic reactions. In this paper we seek to understand how hypergraphs can more faithfully identify, and potentially predict, important genes based on complex relationships inferred from genomic expression data sets.
Results: We compiled a novel data set of transcriptional host response to pathogenic viral infections and formulated relationships between genes as a hypergraph where hyperedges represent significantly perturbed genes, and vertices represent individual biological samples with specific experimental conditions. We find that hypergraph betweenness centrality is a superior method for identification of genes important to viral response when compared with graph centrality.
Conclusions: Our results demonstrate the utility of using hypergraphs to represent complex biological systems and highlight central important responses in common to a variety of highly pathogenic viruses.
Keywords: Biological networks; Host response; Hypergraph; Influenza; MERS; SARS; Systems biology; Viral infection; Viral pathogenesis; West Nile Virus.
Conflict of interest statement
RB has ongoing unrelated collaborations and/or sponsored research agreements with Moderna, VaxArt, Eli Lily, Pfizer, Takeda and Ridgeback Biosciences. MD is a consultant for Inbios, Vir Biotechnology, and Fortressa Biotech and on the Scientific Advisory Boards of Moderna and Immunome. The Diamond laboratory has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology, Kaleido, and Emergent BioSolutions.
Figures





References
-
- Mitchell HD, Eisfeld AJ, Stratton KG, Heller NC, Bramer LM, Wen J, McDermott JE, Gralinski LE, Sims AC, Le MQ, Baric RS, Kawaoka Y, Waters KM. The role of EGFR in influenza pathogenicity: multiple network-based approaches to identify a key regulator of non-lethal infections. Front Cell Dev Biol. 2019;7:200. doi: 10.3389/fcell.2019.00200. - DOI - PMC - PubMed
-
- Adourian A, Jennings E, Balasubramanian R, Hines WM, Damian D, Plasterer TN, Clish CB, Stroobant P, McBurney R, Verheij ER, Bobeldijk I, van der Greef J, Lindberg J, Kenne K, Andersson U, Hellmold H, Nilsson K, Salter H, Schuppe-Koistinen I. Correlation network analysis for data integration and biomarker selection. Mol Biosyst. 2008;4(3):249–59. doi: 10.1039/B708489G. - DOI - PubMed
-
- Diamond DL, Syder AJ, Jacobs JM, Sorensen CM, Walters KA, Proll SC, McDermott JE, Gritsenko MA, Zhang Q, Zhao R, Metz TO, Camp DG, Waters KM, Smith RD, Rice CM, Katze MG. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 2010;6(1):56. doi: 10.1371/journal.ppat.1000719. - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous